News Grower

Independent coverage of AI, startups, and technology.

Ars Technica May 13, 2026 at 10:00 Big Tech Rising Hot

Could this be the moment that drug manufacturing takes off in orbit?

"I do think it's a really good historical moment for the space industry."

Signal weather

Rising

Momentum is building quickly, so this card is a good early entry point into the topic.

By Eric Berger Original source
Could this be the moment that drug manufacturing takes off in orbit?

NASA has enabled scientists to study the impact of microgravity on drug development for decades, beginning with the Space Shuttle. This work accelerated in the 2010s, with the completion of the International Space Station and full-time crew members devoted to scientific research. There have been some notable successes during this timeframe, such as the ability to grow a more uniform crystalline form of the cancer drug Keytruda in 2019. This opened up the possibility of administering the drug via injection rather than requiring a patient to spend hours in a clinic setting to receive the drug intravenously. NASA subsidized much of this work, typically paying the considerable costs to transport research to the ISS and for astronaut time to conduct research there. There were, however, trade-offs, such as long lead times to get research into space. Nevertheless, it has become clear that there could be some commercial applications for making drugs in space. Read full article Comments

Stay on the signal

Follow Could this be the moment that drug manufacturing takes off in orbit?

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

Fresh coverage with immediate momentum.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Ars Technica, Drug Manufacturing, and Historical, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

May 13, 2026 at 10:00 Ars Technica

Could this be the moment that drug manufacturing takes off in orbit?

"I do think it's a really good historical moment for the space industry."

May 12, 2026 at 21:59 Ars Technica

The newest AI boom pitch: Host a mini data center at your home

The plan aims to speed up AI compute deployment while compensating residents.

May 12, 2026 at 21:26 Ars Technica

FDA chief resigns after Trump admin forced approval of fruity e-cigs

Makary reportedly spent his year bucking Trump admin and making industry enemies.

May 12, 2026 at 19:12 Ars Technica

Twin brothers wipe 96 gov't databases minutes after being fired

A case study in why credentials are revoked before firings.

May 12, 2026 at 19:00 Ars Technica

“Will I be OK?” Teen died after ChatGPT pushed deadly mix of drugs, lawsuit says

Teen trusted ChatGPT to help him “safely” experiment with drugs, logs show.

May 12, 2026 at 17:49 Ars Technica

Microsoft will lean on your CPU to speed up Windows 11's apps and animations

"All modern operating systems do this, including macOS and Linux."

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page